Gluomni-M2 for Doctors, Pharmacists and Distributors
Gluomni-M2: Glimepiride & Metformin Hydrochloride (Prolonged Release) Tablets IP
A practical reference on Gluomni-M2 for prescribers, pharmacy teams and trade partners, covering the product profile, Schedule H handling, counselling points and supply.
Gluomni-M2 Product Profile at a Glance
- Brand: Gluomni-M2, marketed by EMK Omni Pharma, Mysuru, Karnataka
- Generic: Glimepiride and Metformin Hydrochloride (Prolonged Release) Tablets IP
- Composition: Glimepiride IP 2 mg and Metformin Hydrochloride IP 500 mg as prolonged release, with approved excipients
- Dosage form: uncoated bilayer tablet
- Pack: 10 X 10 tablets
- Therapy area: Diabetes Care
- Storage: protected from light and moisture, temperature not exceeding 30°C
- Legal: Schedule H prescription drug, not to be sold by retail without the prescription of a registered medical practitioner
Related brands in the range include Gluomni M1 with glimepiride 1 mg, and the Sitomni-M and Sitomni-M-OD sitagliptin with metformin combinations. Tablets are contract manufactured for EMK Omni Pharma at GMP certified units.
Schedule H Handling and Records at the Counter
Dispensing must follow the Drugs and Cosmetics Rules. Supply only against a prescription from a registered medical practitioner, and check that it carries the prescriber's name, registration details, the patient's name, the date, the drug with strength and the quantity.
Retain the prescription or its record as required, maintain the dispensing register, and keep the label carrying the Rx symbol and the mandatory warning intact. Do not substitute another composition without the prescriber's confirmation, and take particular care with look alike strengths within the same range, since Gluomni M1 and Gluomni-M2 differ in glimepiride content. Bills should be issued for every sale, and the batch number and expiry recorded so that any recall can be traced quickly.
Storage and Stock Rotation at the Pharmacy
Metformin in a prolonged release matrix is sensitive to moisture, so pharmacy conditions matter as much as home storage.
- Store below 30°C, away from direct sunlight and from shelving on hot outer walls
- Keep humidity in check during monsoon months, using dehumidifiers or air conditioning where possible in coastal and high rainfall areas
- Follow first expiry first out rotation and audit near expiry stock monthly
- Keep cartons intact, since batch, expiry and MRP details are printed there
- Store away from any spillage prone or wash areas, and off the floor during heavy rain
- Quarantine damaged, water affected or returned stock separately
Train counter staff to inspect strips for torn pockets and discolouration before handing them over.
Patient Counselling Checklist for Gluomni-M2
A short, structured counselling script at the counter improves both adherence and safety.
- Confirm the patient understands the prescribed number of tablets and the meal they are tied to
- Stress that the bilayer prolonged release tablet is swallowed whole, never crushed, chewed or split
- Explain low blood sugar symptoms and the first response with fast acting glucose, and advise carrying sugar
- Warn against skipping meals after taking the tablet, and discuss fasting days in advance
- Advise against alcohol, and ask about steroids, beta blockers, NSAIDs and any ayurvedic preparations
- Remind the patient to inform any doctor or radiology unit before a contrast scan or surgery
- Reinforce home glucose monitoring, HbA1c review and periodic kidney function testing
- Confirm storage below 30°C, away from kitchen and bathroom, and out of reach of children
Advise patients never to share strips with relatives who also have diabetes.
Availability of Gluomni-M2 From EMK Omni Pharma
EMK Omni Pharma supplies its Diabetes Care range to pharmacies, clinics, hospitals and stockists across India. Pharmacies and distributors seeking product information, stock availability, pack details or partnership discussions can reach the company through the contact page on emkomnipharma.com.
For quicker responses on availability and trade enquiries, the team can be reached on WhatsApp at +91 94487 74372. Please have your drug licence details and GST registration ready when opening a trade account, and specify the pack size and quantity required. Product literature and pack artwork can be requested for display and reference at the pharmacy. Adverse events noticed at the counter should be reported through the usual pharmacovigilance route as well as to the company. This article is for general information only and is not a substitute for advice from a registered medical practitioner.
Frequently asked questions
- What is the pack configuration of Gluomni-M2?
- It is supplied as 10 X 10 tablets, that is ten blister strips of ten uncoated bilayer tablets each.
- Can a pharmacist substitute Gluomni M1 when Gluomni-M2 is out of stock?
- No. The glimepiride content differs. Any change in composition needs confirmation from the prescriber.
- Does EMK Omni Pharma manufacture Gluomni-M2 itself?
- The company markets the brand from Mysuru. Manufacturing is done on its behalf at GMP certified units.
- What storage conditions should a pharmacy maintain?
- Below 30°C, protected from light and moisture, with humidity control during the monsoon and first expiry first out rotation.
- How can a distributor open a trade account?
- Use the contact page on emkomnipharma.com or WhatsApp +91 94487 74372, keeping drug licence and GST details ready.
- What are the key counselling points for this product?
- Swallow the tablet whole with a meal, do not skip meals, recognise and treat low blood sugar early, and store the strips below 30°C.
Need Gluomni-M2 for your pharmacy, hospital or clinic?
EMK Omni Pharma supplies through authorised channels across Karnataka. Send an enquiry and our team will respond during business hours.
Related guides
Medical Disclaimer
This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.